Understanding the divergent data on postmenopausal hormone therapy.

In contrast to observational studies, randomized clinical trials of hormone-replacement therapy have not shown a cardioprotective effect. The authors propose several methodologic and biologic explanations for these discrepant results.

[1]  R. Dluhy,et al.  Rethinking postmenopausal hormone therapy. , 2003, The New England journal of medicine.

[2]  Nancy R Cook,et al.  Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. , 2002, The New England journal of medicine.

[3]  H. Sox,et al.  Postmenopausal Hormone Replacement Therapy and the Primary Prevention of Cardiovascular Disease , 2002, Annals of Internal Medicine.

[4]  Charles Kooperberg,et al.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. , 2002, JAMA.

[5]  L. Tavazzi,et al.  Early Protection Against Sudden Death by n-3 Polyunsaturated Fatty Acids After Myocardial Infarction Time-Course Analysis of the Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI)-Prevenzione , 2002 .

[6]  J. Manson,et al.  Blood levels of long-chain n-3 fatty acids and the risk of sudden death. , 2002, The New England journal of medicine.

[7]  T. Clarkson,et al.  Estrogen replacement therapy, atherosclerosis, and vascular function. , 2002, Cardiovascular research.

[8]  A. Coats.  MRC/BHF Heart Protection Study of antioxidant vitamin supplementation in 20 536 high-risk individuals: a randomised placebo-controlled trial , 2002 .

[9]  Robert Selzer,et al.  Estrogen in the Prevention of Atherosclerosis , 2001, Annals of Internal Medicine.

[10]  W. Riley,et al.  Estrogen Replacement and Brachial Artery Flow-Mediated Vasodilation in Older Women , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[11]  A. LaCroix,et al.  Risk of recurrent coronary events in relation to use and recent initiation of postmenopausal hormone therapy. , 2001, Archives of internal medicine.

[12]  J. Manson,et al.  Clinical practice. Postmenopausal hormone-replacement therapy. , 2001, The New England journal of medicine.

[13]  F. Grodstein,et al.  Postmenopausal Hormone Use and Secondary Prevention of Coronary Events in the Nurses' Health Study: A Prospective, Observational Study , 2001, Annals of Internal Medicine.

[14]  M. Thun,et al.  Effect of body mass on the association between estrogen replacement therapy and mortality among elderly US women. , 2001, American journal of epidemiology.

[15]  F. Speizer,et al.  A Prospective, Observational Study of Postmenopausal Hormone Therapy and Primary Prevention of Cardiovascular Disease , 2000, Annals of Internal Medicine.

[16]  R. Cannon,et al.  Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical management. , 2000, Journal of the American College of Cardiology.

[17]  D. Reboussin,et al.  Effects of estrogen replacement on the progression of coronary-artery atherosclerosis. , 2000, The New England journal of medicine.

[18]  A. Hartz,et al.  A comparison of observational studies and randomized, controlled trials , 2000, American journal of ophthalmology.

[19]  E. Rimm,et al.  Antioxidants for vascular disease. , 2000, The Medical clinics of North America.

[20]  E. Barrett-Connor,et al.  Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. , 1999, Circulation.

[21]  F. Grodstein,et al.  Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. , 1999, The American journal of medicine.

[22]  J F Cornhill,et al.  Prevalence and extent of atherosclerosis in adolescents and young adults: implications for prevention from the Pathobiological Determinants of Atherosclerosis in Youth Study. , 1999, JAMA.

[23]  H. Helenius,et al.  Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT) , 1998, The Lancet.

[24]  E. Vittinghoff,et al.  Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. , 1998, JAMA.

[25]  Julian Peto,et al.  Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer , 1997, The Lancet.

[26]  S. Sidney,et al.  Myocardial Infarction and the Use of Estrogen and Estrogen-Progestogen in Postmenopausal Women , 1997, Annals of Internal Medicine.

[27]  J. Manson,et al.  Prospective study of exogenous hormones and risk of pulmonary embolism in women , 1996, The Lancet.

[28]  J. Manson,et al.  Postmenopausal estrogen and progestin use and the risk of cardiovascular disease. , 1996, The New England journal of medicine.

[29]  B. Ettinger,et al.  Reduced Mortality Associated With Long‐Term Postmenopausal Estrogen Therapy , 1996, Obstetrics and gynecology.

[30]  L. Skoog,et al.  Effects of hormone replacement therapy on the mammary gland of surgically postmenopausal cynomolgus macaques. , 1996, American journal of obstetrics and gynecology.

[31]  D. Petitti.  Coronary heart disease and estrogen replacement therapy. Can compliance bias explain the results of observational studies? , 1994, Annals of epidemiology.

[32]  K. Martin,et al.  Postmenopausal hormone-replacement therapy. , 2001, The New England journal of medicine.

[33]  S. Shapiro,et al.  A case-control study of myocardial infarction in relation to use of estrogen supplements. , 1993, American journal of epidemiology.

[34]  Caroline S. Fox,et al.  Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women , 1992, Annals of Internal Medicine.

[35]  B. Henderson,et al.  Decreased Mortality in Users of Estrogen Replacement Therapy , 1991, Archives of internal medicine.

[36]  L. Solberg,et al.  Distribution of coronary and aortic atherosclerosis by geographic location, race, and sex. , 1968, Laboratory investigation; a journal of technical methods and pathology.